AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.
Tagged By shenzhen
Eyeing China threat, Trump announces Boeing wins contract for secretive future fighter jet
WASHINGTON (AP) — President Donald Trump announced Friday that Boeing will build the Air Force’s future fighter jet, which the Pentagon says will have stealth and penetration capabilities that far exceed those of its current…
Meituan joins China’s AI spending race, says investing ‘billions’ in chips
Wang Xing, CEO of China’s largest food delivery firm Meituan , said on Friday in a post-earnings call that the company is pouring “billions” into chips used to train AI models, with more investment planned…
Musk To Visit Pentagon, Denies China War Plan Briefing Rumors: Live Updates
Musk to visit Pentagon Friday; officials deny reports he’ll be briefed on China war plans, calling claims “false” and “malicious.” Follow Newsweek’s live blog.
AstraZeneca to invest $2.5 billion in Beijing hub as it seeks to move on from China probes
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the Chinese capital.
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its…
China to strengthen oversight of fees charged to businesses, cabinet meeting says
China will strengthen oversight of the fees government agencies charge to businesses, state broadcaster CCTV reported on Friday, citing a cabinet meeting.
China asks lenders to raise credit limit for consumer loans, report says
China has asked banks to raise credit limits for consumer loans, financial media outlet 21jingji reported on Friday, as part of its efforts to boost consumption to revive a slowing economy.
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China.
CK Hutchison shares drop after earnings, pro-Beijing paper’s fresh criticism cites security laws
CK Hutchison’s shares fell on Friday after it reported weak earnings and dividends, while pro-Beijing newspaper published a fresh editorial saying the firm’s controversial port sale could potentially …
As China tackles aging, elderly care robots hit fast track
China is witnessing a rapid integration of artificial intelligence (AI) and robotics into eldercare services, offering innovative solutions to the challenges of an aging population.
China says facial recognition should not be forced on individuals
China’s cyberspace regulator on Friday published regulations governing the use of facial recognition technology, separately stating that entities should not force individuals to verify their identity using facial recognition technology.
US Targets China’s ‘Teapot’ Oil Refiners to Choke Iran
Washington has issued new Iran-related sanctions, including a Chinese “teapot,” or independent refiner, and vessels that supply oil.
